<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Phil</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Jauch, Edward C.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Defending the Stroke Guidelines</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-04-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">8-10</style></pages><abstract><style  face="normal" font="default" size="100%">At this year's International Stroke Conference, leaders in the field of stroke met to review some of the important updates to stroke-related guidelines. Included are some of the important revisions to the Guidelines for the Early Management of Patients With Acute Ischemic Stroke [Jauch EC et al. Stroke 2013]; 2012 Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage; an overview and recommendations for the use of the warfarin, dabigatran, apixaban, and rivaroxaban; and a discussion of the relationship between stroke and cardiovascular disease.</style></abstract><number><style face="normal" font="default" size="100%">1</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>